Q. Hong
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Advanced Breast Cancer Therapies
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 5
- Cancer Treatment and Pharmacology 2
- HER2/EGFR in Cancer Research 2
- CAR-T cell therapy research 2
-
- Advanced Breast Cancer Therapies 2
- Prostate Cancer Treatment and Research 1
- Co-authors
- Trishna Goswami (4 shared papers)Sara M. Tolaney (2 shared papers)Joyce O’Shaughnessy (2 shared papers)Kevin Kalinsky (2 shared papers)Aditya Bardia (2 shared papers)Robert M. Sharkey (1 shared paper)Jennifer R. Diamond (1 shared paper)William A. Wegener (1 shared paper)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Q. Hong
7 papers receiving 234 citations
Peers
Comparison fields: 5 of 30
- Oncology 197
- Pulmonary and Respiratory Medicine 96
- Radiology, Nuclear Medicine and Imaging 52
- Cancer Research 26
- Genetics 17
Countries citing papers authored by Q. Hong
This map shows the geographic impact of Q. Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Q. Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Q. Hong more than expected).
Fields of papers citing papers by Q. Hong
This network shows the impact of papers produced by Q. Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Q. Hong. The network helps show where Q. Hong may publish in the future.
Co-authors
The 25 scholars most cited alongside Q. Hong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 111 | |
| 2 | 2020 | 51 | |
| 3 | 2019 | 20 | |
| 4 | 2020 | 19 | |
| 5 | 2014 | 18 | |
| 6 | 2014 | 17 | |
| 7 | 2020 | 3 | |
| 8 | 2022 | 0 |
About Q. Hong
Q. Hong is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Genetics, having authored 8 papers that have together received 239 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Bladder and Urothelial Cancer Treatments (3 papers), Advanced Breast Cancer Therapies (2 papers), Cancer Treatment and Pharmacology (2 papers), HER2/EGFR in Cancer Research (2 papers), CAR-T cell therapy research (2 papers), Prostate Cancer Treatment and Research (1 paper) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (197 citations), Pulmonary and Respiratory Medicine (96 citations), Radiology, Nuclear Medicine and Imaging (52 citations), Cancer Research (26 citations) and Genetics (17 citations). Q. Hong has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Trishna Goswami, Sara M. Tolaney, Joyce O’Shaughnessy, Kevin Kalinsky, Aditya Bardia, Robert M. Sharkey, Jennifer R. Diamond, William A. Wegener, Vandana G. Abramson and IA Mayer. Their work appears in journals such as Annals of Oncology and Leukemia Research Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.